An Overview of the 2022 MPOX Whirlwind

MPOX has primarily been a threat to humans living in tropical areas of western and central Africa, with outbreaks in non-endemic areas sparked by the exotic pet trade and international travel. The 2022 global outbreak, with nearly 90,000 cases in over 100 countries, shined a light on this otherwise neglected zoonotic tropic disease.  This presentation will describe the epidemiology of mpox in humans, including the clinical course, treatment, and infection prevention strategies, vaccine availability and eligibility, and ongoing research to further understand this disease.